Companies
Stay informed about the latest developments and news from cannabis companies with Business of Cannabis. Learn about new products, mergers and acquisitions, and more.
Companies · page 32
- Companies
UK’s Lyphe Group secures £5m funding to expand into Europe
The funding round was led by Europe’s first cannabis and psychedelics fund, Leafy Tunnel.
- Companies
Kendra Mark appointed as director of product at Tenacious Labs
Mark has a passion for health and wellness.
- Adult-Use
Q&A with John Mazarakis: co-founder of a $1B cannabis lender
Cannabis lender Chicago Atlantic had its IPO in December 2021 after four years as a private company.
- Companies
US cannabis tech company BLAZE acquires POS software Greenline
The acquisition sees BLAZE expand to Canada as part of a strategic move to enter a federally regulated market.
- Companies
Bright Green stock continues to rise following direct listing on NASDAQ
The cannabis producer’s stock shot up by 215 per cent on its first day of trading followed by a further 91 per cent increase yesterday.
- Pharmaceutical
Roundup of Q1 2022 financial results in the UK medical cannabis space
Companies across the cannabis industry announce financial results for the first quarter of 2022, Cannabis Wealth rounds up the results of six major firms expanding within the UK medical cannabis space. 2021 was a positive year for cannabis businesses with 165 per cent year-over-year growth in cannabis equity capital raises and a series of high…
- Companies
Cellular Goods makes changes to board, welcoming author as NED
The company is welcoming new non-executive directors (NED) to the board.
- Companies
Expanding the full digitisation of COAs in the cannabis supply chain
Lucid Green has announced three new partnerships to support the digitisation of certificates of analysis (COA).
- Adult-Use
Curaleaf appoints Matt Darin as new CEO
Curaleaf’s current CEO Joe Bayern will launch and run a new division of Curaleaf.
- CBD Market
Love Hemp to appoint new AQSE corporate advisor
The appointment will be made following suspension of the company’s shares from the AQSE.
- Companies
Apollon Formularies purchases four patents from Aion Therapeutic
Apollon Formularies has announced the acquisition of four patents previously owned by AI Pharmaceuticals, covering a number of treatments for cancers and inflammation using cannabis and mushroom compositions.
